Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multiple Myeloma Molecular Monitoring Study
Sponsor: Horizon Health Network
Summary
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
Official title: The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Key Details
Gender
All
Age Range
19 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
96
Start Date
2018-02-20
Completion Date
2026-03-31
Last Updated
2025-06-29
Healthy Volunteers
No
Conditions
Locations (9)
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
CancerCare Manitoba
Winnipeg, Manitoba, Canada
Saint John Regional Hospital (Horizon Health Network)
Saint John, New Brunswick, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
Buland Mangukia
Hamilton, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada